loading page

Rituximab successful in COVID-19 vaccine-induced refractory pemphigus vulgaris
  • +3
  • Hai-Zhen HUI,
  • Ying-Jun WANG,
  • Jia-Rong CHENG,
  • Han MAO,
  • Hong-Xing GUO,
  • Bingjun SHI
Hai-Zhen HUI
Chongqing City Hospital of Traditional Chinese Medicine

Corresponding Author:[email protected]

Author Profile
Ying-Jun WANG
Chongqing City Hospital of Traditional Chinese Medicine
Author Profile
Jia-Rong CHENG
Chongqing City Hospital of Traditional Chinese Medicine
Author Profile
Han MAO
Chongqing City Hospital of Traditional Chinese Medicine
Author Profile
Hong-Xing GUO
Kweichow Moutai Group
Author Profile
Bingjun SHI
Chongqing City Hospital of Traditional Chinese Medicine
Author Profile

Abstract

Coronavirus disease 2019 (COVID-19) is the most prevalent disease in society today, and vaccination is a powerful weapon against COVID-19. However, there have been many recent reports of vaccine-induced skin side effects. Autoimmune bullous reactions caused by the COVID-19 vaccine are rare. We identified a case of refractory PV associated with COVID-19 vaccination that improved after 2 RTX injections.